Skip to main content
Log in

Serum levels of myoglobin and creatine kinase in duchenne muscular dystrophy

Serumkonzentrationen von Myoglobin und Kreatin Kinase bei progressiver Muskeldystrophie vom Typ Duchenne

  • Kurze Wissenschaftliche Mitteilungen
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Using a sensitive myoglobin-radioimmunoassay (Mb-RIA) serum Mb was measured in 50 patients with Duchenne muscular dystrophy (DMD) and compared with the serum creatine kinase (CK) activities. The Mb concentrations (normal range 4–60 ng/ml) measured ranged between 160–6,000 ng/ml and did not only show a significant correlation to the CK but also an inverse relationship to the age of the patients. It is suggested that Mb is an essential adjunct in the diagnosis of DMD.

Zusammenfassung

Mit einem empfindlichen Myoglobin-Radioimmunoassay (Mb-RIA) wurde bei 50 Patienten mit progressiver Muskeldystrophie vom Typ Duchenne (MDD) die Serum Mb-Konzentration gemessen und mit der Serum Kreatin Kinase (CK)-Aktivität verglichen. Die Mb-Konzentrationen (Normalbereich 4–60 ng/ml) bewegten sich zwischen 160–6000 ng/ml und ließen eine signifikante Korrelation zur CK und eine inverse Korrelation zum Alter der Patienten erkennen. Die Mb-Bestimmung im Serum kann somit als zusätzlicher Parameter bei der Diagnose der MDD herangezogen werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Adornato BT, Kagen LJ, Engel WK (1978) Myoglobinemia in Duchenne muscular dystrophy patients and carriers: a new adjunct to carrier detection. Lancet 2:499–501

    PubMed  Google Scholar 

  2. Hische EAH, van der Helm HJ (1979) The significance of serum myoglobin in neuromuscular diseases. J Neurol Sci 43:243–251

    PubMed  Google Scholar 

  3. Kagen LJ, Scheidt S, Roberts L (1975) Myoglobinemia following acute myocardial infarction. Am J Med 58:177–182

    PubMed  Google Scholar 

  4. Kagen LJ, Scheidt S, Butt A (1977) Serum myoglobin in myocardial infarction: the staccato phenomenon. Am J Med 62:86–92

    PubMed  Google Scholar 

  5. Kagen LJ, Moussavi S, Miller ST, Tsairis P (1980) Serum myoglobin in muscular dystrophy. Muscle Nerve 3:221–226

    PubMed  Google Scholar 

  6. Kießling WR, Ricker K, Pflughaupt KW, Mertens HG, Haubitz I (1981) Serum myoglobin in primary and secondary skeletal muscle disorders. J Neurol (in press)

  7. Kießling WR, Pflughaupt KW: Unpublished

  8. Miyoshi K, Saito S, Kawai H, Kondo A, Iwas M, Hayashi T, Yagita M (1978) Radioimmunoassay for human myoglobin: method and results in patients with skeletal muscle and myocardial disorders. J Lab Clin Med 92:341–352

    PubMed  Google Scholar 

  9. Rosano TG, Sanders LA, Johnson ES, Kenny MA, Clayson KJ, Strandjord PE (1977) Myoglobin concentrations and muscle enzyme activities in serum after myocardial infarction and in cardiac arrhythmia. Clin Chem 23:868–870

    PubMed  Google Scholar 

  10. Stone MJ, Waterman MR, Harimoto D, Murray G, Wilson N, Platt MR, Blomquist G, Willerson JT (1977) Serum myoglobin level as a diagnostic test in patients with acute myocardial infarction. Br Heart J 39:375–380

    PubMed  Google Scholar 

  11. Zundel WS, Tyler FH (1965) The muscular dystrophies. N Engl J Med 273:537–543, 596–601

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kießling, W.R., Beckmann, R. Serum levels of myoglobin and creatine kinase in duchenne muscular dystrophy. Klin Wochenschr 59, 347–348 (1981). https://doi.org/10.1007/BF01525003

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01525003

Key words

Schlüsselwörter

Navigation